Australia's PolyNovo chief steps down after reports of rift with chair

Reuters
03-11
UPDATE 2-Australia's PolyNovo chief steps down after reports of rift with chair

Updates with share moves, adds sourcing in paragraph 7

March 11 (Reuters) - Australian biotech company PolyNovo PNV.AX said on Tuesday it has removed its CEO after discussions with the executive last week following media allegations about bullying by the firm's chairman directed at its CEO.

Shares of the company fell as much as 7.2% to A$1.165 at 2313 GMT, its lowest level since November 1, 2023.

The Australian newspaper has published a series of reports alleging "bullying" by chairman David Williams against CEO Swami Raote and finance head Jan Gielen.

Raote will be replaced by current non-executive director Robyn Elliot as the acting CEO until a permanent replacement is found.

The company earlier this month said it had held talks with Raote over an agreement for him to leave the firm - a plan that would have seen Elliott step in as interim CEO.

It remains unclear why the board held confidential discussions with the CEO about stepping down. Raote could not immediately be reached for comment.

The Australian reported that PolyNovo's board had engaged barristers Philip Crutchfield KC and Katherine Brazenor in October last year to hold discussions with management team members regarding issues raised about interactions between Williams and some members.

Following interviews with senior staff, Crutchfield and Brazenor recommended Williams step down as chairman, the report added.

(Reporting by Adwitiya Srivastava in Bengaluru; Editing by Tasim Zahid)

((Adwitiya.Srivastava@thomsonreuters.com;))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10